These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3311923)
1. Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma. Belinson JL; McClure M; Badger G Gynecol Oncol; 1987 Oct; 28(2):151-5. PubMed ID: 3311923 [TBL] [Abstract][Full Text] [Related]
2. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group. Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393 [TBL] [Abstract][Full Text] [Related]
3. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer. Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927 [TBL] [Abstract][Full Text] [Related]
4. Megestrol acetate in advanced breast carcinoma. Espie M Oncology; 1994 Oct; 51 Suppl 1():8-12. PubMed ID: 7970508 [TBL] [Abstract][Full Text] [Related]
5. Megestrol acetate for the palliation of advanced ovarian carcinoma. Geisler HE Obstet Gynecol; 1983 Jan; 61(1):95-8. PubMed ID: 6185891 [TBL] [Abstract][Full Text] [Related]
6. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association. Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710 [TBL] [Abstract][Full Text] [Related]
7. Megestrol acetate: clinical experience. Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590 [TBL] [Abstract][Full Text] [Related]
8. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide. Brufman G; Isacson R; Haim N; Gez E; Sulkes A Oncology; 1994; 51(3):258-61. PubMed ID: 8196908 [TBL] [Abstract][Full Text] [Related]
9. Megestrol acetate in relapsed carcinoma of prostate. Daniel F; MacLeod PM; Tyrrell CJ Br J Urol; 1990 Mar; 65(3):275-7. PubMed ID: 2186841 [TBL] [Abstract][Full Text] [Related]
10. Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study). Alexieva-Figusch J; Van Putten WL; van Gilse HA; Blonk-vd Wijst J; Klijn JG Med Oncol Tumor Pharmacother; 1985; 2(2):69-75. PubMed ID: 4058078 [TBL] [Abstract][Full Text] [Related]
11. Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program. Ahlgren JD; Ellison NM; Gottlieb RJ; Laluna F; Lokich JJ; Sinclair PR; Ueno W; Wampler GL; Yeung KY; Alt D J Clin Oncol; 1993 Oct; 11(10):1957-68. PubMed ID: 7691999 [TBL] [Abstract][Full Text] [Related]
12. Megestrol acetate: first-line therapy for advanced breast cancer. Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124 [TBL] [Abstract][Full Text] [Related]
13. The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma. Geisler HE Semin Oncol; 1985 Mar; 12(1 Suppl 1):20-2. PubMed ID: 3975647 [TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer. Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654 [TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate. Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327 [TBL] [Abstract][Full Text] [Related]
16. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA). Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503 [TBL] [Abstract][Full Text] [Related]
17. Experience with hormonal therapy in advanced epithelial ovarian cancer. van der Vange N; Greggi S; Burger CW; Kenemans P; Vermorken JB Acta Oncol; 1995; 34(6):813-20. PubMed ID: 7576750 [TBL] [Abstract][Full Text] [Related]
18. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer. Alexieva-Figusch J; Blankenstein MA; de Jong FH; Lamberts SW Eur J Cancer Clin Oncol; 1984 Sep; 20(9):135-40. PubMed ID: 6434315 [TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen. Ross MB; Buzdar AU; Blumenschein GR Cancer; 1982 Feb; 49(3):413-7. PubMed ID: 6174195 [TBL] [Abstract][Full Text] [Related]
20. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen. Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]